ID   PPIE_HUMAN              Reviewed;         301 AA.
AC   Q9UNP9; B2R971; O43634; O43635; Q32Q72; Q3S611; Q5TGA0; Q5TGA2;
AC   Q5TGA3; Q9UIZ5;
DT   21-FEB-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2000, sequence version 1.
DT   10-MAY-2017, entry version 173.
DE   RecName: Full=Peptidyl-prolyl cis-trans isomerase E;
DE            Short=PPIase E;
DE            EC=5.2.1.8;
DE   AltName: Full=Cyclophilin E;
DE   AltName: Full=Cyclophilin-33;
DE   AltName: Full=Rotamase E;
GN   Name=PPIE; Synonyms=CYP33;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS A AND B).
RX   PubMed=9747881; DOI=10.1038/sj.onc.1202006;
RA   Kim J.-O., Nau M.M., Allikian K.A., Makela T.P., Alitalo K.,
RA   Johnson B.E., Kelley M.J.;
RT   "Co-amplification of a novel cyclophilin-like gene (PPIE) with L-myc
RT   in small cell lung cancer cell lines.";
RL   Oncogene 17:1019-1026(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS A AND B).
RA   Slater C., Thill G., Obar R.;
RL   Submitted (JAN-1998) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3).
RA   Zhou G., Nong W., Li H., Ke R., Shen C., Zhong G., Zheng Z., Liang M.,
RA   Tang Z., Huang B., Lin L., Yang S.;
RL   Submitted (AUG-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM A).
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM A).
RC   TISSUE=Bone marrow, Colon, and Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   CHARACTERIZATION.
RX   PubMed=8977107; DOI=10.1016/S0014-5793(96)01248-3;
RA   Mi H., Kops O., Zimmermann E., Jaeschke A., Tropschug M.;
RT   "A nuclear RNA-binding cyclophilin in human T cells.";
RL   FEBS Lett. 398:201-205(1996).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY, AND IDENTIFICATION IN THE
RP   SPLICEOSOMAL C COMPLEX.
RX   PubMed=11991638; DOI=10.1017/S1355838202021088;
RA   Jurica M.S., Licklider L.J., Gygi S.P., Grigorieff N., Moore M.J.;
RT   "Purification and characterization of native spliceosomes suitable for
RT   three-dimensional structural analysis.";
RL   RNA 8:426-439(2002).
RN   [10]
RP   IDENTIFICATION AS PART OF THE XAB2 COMPLEX.
RX   PubMed=17981804; DOI=10.1074/jbc.M706647200;
RA   Kuraoka I., Ito S., Wada T., Hayashida M., Lee L., Saijo M.,
RA   Nakatsu Y., Matsumoto M., Matsunaga T., Handa H., Qin J., Nakatani Y.,
RA   Tanaka K.;
RT   "Isolation of XAB2 complex involved in pre-mRNA splicing,
RT   transcription, and transcription-coupled repair.";
RL   J. Biol. Chem. 283:940-950(2008).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-91 AND SER-97, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-119, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [14]
RP   STRUCTURE BY NMR OF 1-89.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of the RNA recognition motif in peptidyl-prolyl
RT   cis-trans isomerase E.";
RL   Submitted (NOV-2005) to the PDB data bank.
CC   -!- FUNCTION: PPIases accelerate the folding of proteins. It catalyzes
CC       the cis-trans isomerization of proline imidic peptide bonds in
CC       oligopeptides. Combines RNA-binding and PPIase activities. May be
CC       involved in muscle- and brain-specific processes. May be involved
CC       in pre-mRNA splicing.
CC   -!- CATALYTIC ACTIVITY: Peptidylproline (omega=180) = peptidylproline
CC       (omega=0).
CC   -!- SUBUNIT: Identified in the spliceosome C complex. Component of the
CC       XAB2 complex, a multimeric protein complex composed of XAB2,
CC       PRPF19, AQR, ZNF830, ISY1, and PPIE. {ECO:0000269|PubMed:11991638,
CC       ECO:0000269|PubMed:17981804}.
CC   -!- INTERACTION:
CC       Q03164:KMT2A; NbExp=4; IntAct=EBI-591818, EBI-591370;
CC       Q9HCS7:XAB2; NbExp=8; IntAct=EBI-591818, EBI-295232;
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=A;
CC         IsoId=Q9UNP9-1; Sequence=Displayed;
CC       Name=B;
CC         IsoId=Q9UNP9-2; Sequence=VSP_005181;
CC       Name=3; Synonyms=Cyclophilin-33B;
CC         IsoId=Q9UNP9-3; Sequence=VSP_046370;
CC   -!- TISSUE SPECIFICITY: Found in all the examined tissues including
CC       heart, brain, placenta, lung, liver, skeletal muscle, kidney and
CC       pancreas.
CC   -!- SIMILARITY: Belongs to the cyclophilin-type PPIase family. PPIase
CC       E subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF104012; AAD19906.1; -; mRNA.
DR   EMBL; AF104013; AAD19907.1; -; mRNA.
DR   EMBL; AF042385; AAC00006.1; -; mRNA.
DR   EMBL; AF042386; AAC00007.1; -; mRNA.
DR   EMBL; DQ160195; AAZ93379.1; -; mRNA.
DR   EMBL; AK313666; BAG36418.1; -; mRNA.
DR   EMBL; AL049824; CAI19347.1; -; Genomic_DNA.
DR   EMBL; AL033527; CAI19347.1; JOINED; Genomic_DNA.
DR   EMBL; AL035404; CAI19347.1; JOINED; Genomic_DNA.
DR   EMBL; AL049824; CAI19348.1; -; Genomic_DNA.
DR   EMBL; AL033527; CAI19348.1; JOINED; Genomic_DNA.
DR   EMBL; AL035404; CAI19348.1; JOINED; Genomic_DNA.
DR   EMBL; AL049824; CAI19350.1; -; Genomic_DNA.
DR   EMBL; AL035404; CAI19350.1; JOINED; Genomic_DNA.
DR   EMBL; AL033527; CAI19409.1; -; Genomic_DNA.
DR   EMBL; AL035404; CAI19409.1; JOINED; Genomic_DNA.
DR   EMBL; AL049824; CAI19409.1; JOINED; Genomic_DNA.
DR   EMBL; AL033527; CAI19410.1; -; Genomic_DNA.
DR   EMBL; AL035404; CAI19410.1; JOINED; Genomic_DNA.
DR   EMBL; AL049824; CAI19410.1; JOINED; Genomic_DNA.
DR   EMBL; AL035404; CAI19576.1; -; Genomic_DNA.
DR   EMBL; AL033527; CAI19576.1; JOINED; Genomic_DNA.
DR   EMBL; AL049824; CAI19576.1; JOINED; Genomic_DNA.
DR   EMBL; AL035404; CAI19577.1; -; Genomic_DNA.
DR   EMBL; AL033527; CAI19577.1; JOINED; Genomic_DNA.
DR   EMBL; AL049824; CAI19577.1; JOINED; Genomic_DNA.
DR   EMBL; AL035404; CAI19579.1; -; Genomic_DNA.
DR   EMBL; AL049824; CAI19579.1; JOINED; Genomic_DNA.
DR   EMBL; CH471059; EAX07255.1; -; Genomic_DNA.
DR   EMBL; BC004898; AAH04898.1; -; mRNA.
DR   EMBL; BC008451; AAH08451.1; -; mRNA.
DR   EMBL; BC107736; AAI07737.1; -; mRNA.
DR   CCDS; CCDS442.1; -. [Q9UNP9-2]
DR   CCDS; CCDS443.1; -. [Q9UNP9-1]
DR   CCDS; CCDS53299.1; -. [Q9UNP9-3]
DR   PIR; S66681; S66681.
DR   RefSeq; NP_001181936.1; NM_001195007.1. [Q9UNP9-3]
DR   RefSeq; NP_006103.1; NM_006112.3. [Q9UNP9-1]
DR   RefSeq; NP_982281.1; NM_203456.2. [Q9UNP9-2]
DR   RefSeq; XP_016855540.1; XM_017000051.1. [Q9UNP9-3]
DR   UniGene; Hs.524690; -.
DR   PDB; 1ZMF; X-ray; 1.88 A; A=137-301.
DR   PDB; 2CQB; NMR; -; A=1-89.
DR   PDB; 2KU7; NMR; -; A=2-82.
DR   PDB; 2KYX; NMR; -; A=3-83.
DR   PDB; 2R99; X-ray; 1.61 A; A=131-301.
DR   PDB; 3LPY; X-ray; 2.00 A; A/B=5-82.
DR   PDB; 3MDF; X-ray; 1.85 A; A/B=1-83.
DR   PDB; 3UCH; X-ray; 2.50 A; A=129-301.
DR   PDB; 5MQF; EM; 5.90 A; o=1-301.
DR   PDBsum; 1ZMF; -.
DR   PDBsum; 2CQB; -.
DR   PDBsum; 2KU7; -.
DR   PDBsum; 2KYX; -.
DR   PDBsum; 2R99; -.
DR   PDBsum; 3LPY; -.
DR   PDBsum; 3MDF; -.
DR   PDBsum; 3UCH; -.
DR   PDBsum; 5MQF; -.
DR   ProteinModelPortal; Q9UNP9; -.
DR   SMR; Q9UNP9; -.
DR   BioGrid; 115714; 56.
DR   DIP; DIP-34757N; -.
DR   IntAct; Q9UNP9; 13.
DR   MINT; MINT-3082792; -.
DR   iPTMnet; Q9UNP9; -.
DR   PhosphoSitePlus; Q9UNP9; -.
DR   BioMuta; PPIE; -.
DR   DMDM; 13124097; -.
DR   EPD; Q9UNP9; -.
DR   PeptideAtlas; Q9UNP9; -.
DR   PRIDE; Q9UNP9; -.
DR   TopDownProteomics; Q9UNP9-1; -. [Q9UNP9-1]
DR   TopDownProteomics; Q9UNP9-2; -. [Q9UNP9-2]
DR   DNASU; 10450; -.
DR   Ensembl; ENST00000324379; ENSP00000312769; ENSG00000084072. [Q9UNP9-1]
DR   Ensembl; ENST00000356511; ENSP00000348904; ENSG00000084072. [Q9UNP9-2]
DR   Ensembl; ENST00000372830; ENSP00000361918; ENSG00000084072. [Q9UNP9-3]
DR   GeneID; 10450; -.
DR   KEGG; hsa:10450; -.
DR   UCSC; uc001cds.3; human. [Q9UNP9-1]
DR   CTD; 10450; -.
DR   DisGeNET; 10450; -.
DR   GeneCards; PPIE; -.
DR   HGNC; HGNC:9258; PPIE.
DR   HPA; HPA019357; -.
DR   HPA; HPA020131; -.
DR   MIM; 602435; gene.
DR   neXtProt; NX_Q9UNP9; -.
DR   OpenTargets; ENSG00000084072; -.
DR   PharmGKB; PA33583; -.
DR   GeneTree; ENSGT00760000119119; -.
DR   HOGENOM; HOG000065981; -.
DR   HOVERGEN; HBG001065; -.
DR   InParanoid; Q9UNP9; -.
DR   KO; K09564; -.
DR   OMA; IAKPMRI; -.
DR   OrthoDB; EOG091G0BGL; -.
DR   PhylomeDB; Q9UNP9; -.
DR   TreeFam; TF313817; -.
DR   BRENDA; 5.2.1.8; 2681.
DR   Reactome; R-HSA-6781823; Formation of TC-NER Pre-Incision Complex.
DR   Reactome; R-HSA-6781827; Transcription-Coupled Nucleotide Excision Repair (TC-NER).
DR   Reactome; R-HSA-6782135; Dual incision in TC-NER.
DR   Reactome; R-HSA-6782210; Gap-filling DNA repair synthesis and ligation in TC-NER.
DR   Reactome; R-HSA-6798695; Neutrophil degranulation.
DR   Reactome; R-HSA-72163; mRNA Splicing - Major Pathway.
DR   ChiTaRS; PPIE; human.
DR   EvolutionaryTrace; Q9UNP9; -.
DR   GeneWiki; PPIE_(gene); -.
DR   GenomeRNAi; 10450; -.
DR   PRO; PR:Q9UNP9; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000084072; -.
DR   CleanEx; HS_PPIE; -.
DR   ExpressionAtlas; Q9UNP9; baseline and differential.
DR   Genevisible; Q9UNP9; HS.
DR   GO; GO:0071013; C:catalytic step 2 spliceosome; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:1904813; C:ficolin-1-rich granule lumen; TAS:Reactome.
DR   GO; GO:0016607; C:nuclear speck; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0034774; C:secretory granule lumen; TAS:Reactome.
DR   GO; GO:0016018; F:cyclosporin A binding; TAS:ProtInc.
DR   GO; GO:0003755; F:peptidyl-prolyl cis-trans isomerase activity; TAS:UniProtKB.
DR   GO; GO:0003723; F:RNA binding; IDA:UniProtKB.
DR   GO; GO:0000398; P:mRNA splicing, via spliceosome; TAS:Reactome.
DR   GO; GO:0043312; P:neutrophil degranulation; TAS:Reactome.
DR   GO; GO:0045070; P:positive regulation of viral genome replication; IMP:UniProtKB.
DR   GO; GO:0006457; P:protein folding; IEA:InterPro.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IMP:UniProtKB.
DR   GO; GO:0006283; P:transcription-coupled nucleotide-excision repair; TAS:Reactome.
DR   CDD; cd12347; RRM_PPIE; 1.
DR   Gene3D; 2.40.100.10; -; 1.
DR   InterPro; IPR029000; Cyclophilin-like_dom.
DR   InterPro; IPR024936; Cyclophilin-type_PPIase.
DR   InterPro; IPR020892; Cyclophilin-type_PPIase_CS.
DR   InterPro; IPR002130; Cyclophilin-type_PPIase_dom.
DR   InterPro; IPR016304; PPIE.
DR   InterPro; IPR034168; PPIE_RRM.
DR   InterPro; IPR000504; RRM_dom.
DR   PANTHER; PTHR11071; PTHR11071; 1.
DR   Pfam; PF00160; Pro_isomerase; 1.
DR   Pfam; PF00076; RRM_1; 1.
DR   PIRSF; PIRSF001475; PPI_cyclophilin_E; 1.
DR   PRINTS; PR00153; CSAPPISMRASE.
DR   SMART; SM00360; RRM; 1.
DR   SUPFAM; SSF50891; SSF50891; 1.
DR   SUPFAM; SSF54928; SSF54928; 1.
DR   PROSITE; PS00170; CSA_PPIASE_1; 1.
DR   PROSITE; PS50072; CSA_PPIASE_2; 1.
DR   PROSITE; PS50102; RRM; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Complete proteome; Isomerase;
KW   mRNA processing; mRNA splicing; Nucleus; Phosphoprotein;
KW   Reference proteome; RNA-binding; Rotamase; Spliceosome.
FT   CHAIN         1    301       Peptidyl-prolyl cis-trans isomerase E.
FT                                /FTId=PRO_0000064157.
FT   DOMAIN        6     84       RRM. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00176}.
FT   DOMAIN      143    299       PPIase cyclophilin-type.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00156}.
FT   COMPBIAS     60     63       Poly-Ala.
FT   MOD_RES      91     91       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES      97     97       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     119    119       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   VAR_SEQ     280    301       AQGSKDGKPKQKVIIADCGEYV -> VAPDTKASKARGSRK
FT                                NKDGQERNWGKSQKVESHTI (in isoform 3).
FT                                {ECO:0000303|Ref.3}.
FT                                /FTId=VSP_046370.
FT   VAR_SEQ     280    301       AQGSKDGKPKQKVIIADCGEYV -> KQEESAITSQPRSWK
FT                                LT (in isoform B).
FT                                {ECO:0000303|PubMed:9747881,
FT                                ECO:0000303|Ref.2}.
FT                                /FTId=VSP_005181.
FT   CONFLICT    151    151       K -> R (in Ref. 3; AAZ93379).
FT                                {ECO:0000305}.
FT   CONFLICT    207    207       N -> D (in Ref. 3; AAZ93379).
FT                                {ECO:0000305}.
FT   CONFLICT    287    287       K -> N (in Ref. 2; AAC00006).
FT                                {ECO:0000305}.
FT   STRAND        5     11       {ECO:0000244|PDB:3MDF}.
FT   HELIX        19     26       {ECO:0000244|PDB:3MDF}.
FT   HELIX        27     29       {ECO:0000244|PDB:3MDF}.
FT   STRAND       32     36       {ECO:0000244|PDB:3MDF}.
FT   TURN         41     43       {ECO:0000244|PDB:3MDF}.
FT   STRAND       48     56       {ECO:0000244|PDB:3MDF}.
FT   HELIX        57     67       {ECO:0000244|PDB:3MDF}.
FT   STRAND       70     72       {ECO:0000244|PDB:2CQB}.
FT   STRAND       78     81       {ECO:0000244|PDB:3MDF}.
FT   STRAND      141    148       {ECO:0000244|PDB:2R99}.
FT   STRAND      151    160       {ECO:0000244|PDB:2R99}.
FT   TURN        162    164       {ECO:0000244|PDB:2R99}.
FT   HELIX       166    177       {ECO:0000244|PDB:2R99}.
FT   TURN        178    180       {ECO:0000244|PDB:2R99}.
FT   STRAND      188    193       {ECO:0000244|PDB:2R99}.
FT   TURN        194    196       {ECO:0000244|PDB:2R99}.
FT   STRAND      197    200       {ECO:0000244|PDB:2R99}.
FT   TURN        203    205       {ECO:0000244|PDB:2R99}.
FT   STRAND      206    209       {ECO:0000244|PDB:2R99}.
FT   STRAND      214    217       {ECO:0000244|PDB:3UCH}.
FT   STRAND      230    236       {ECO:0000244|PDB:2R99}.
FT   STRAND      248    253       {ECO:0000244|PDB:2R99}.
FT   HELIX       256    258       {ECO:0000244|PDB:2R99}.
FT   TURN        259    261       {ECO:0000244|PDB:2R99}.
FT   STRAND      264    270       {ECO:0000244|PDB:2R99}.
FT   HELIX       272    279       {ECO:0000244|PDB:2R99}.
FT   STRAND      292    299       {ECO:0000244|PDB:2R99}.
SQ   SEQUENCE   301 AA;  33431 MW;  F3226149A790BA42 CRC64;
     MATTKRVLYV GGLAEEVDDK VLHAAFIPFG DITDIQIPLD YETEKHRGFA FVEFELAEDA
     AAAIDNMNES ELFGRTIRVN LAKPMRIKEG SSRPVWSDDD WLKKFSGKTL EENKEEEGSE
     PPKAETQEGE PIAKKARSNP QVYMDIKIGN KPAGRIQMLL RSDVVPMTAE NFRCLCTHEK
     GFGFKGSSFH RIIPQFMCQG GDFTNHNGTG GKSIYGKKFD DENFILKHTG PGLLSMANSG
     PNTNGSQFFL TCDKTDWLDG KHVVFGEVTE GLDVLRQIEA QGSKDGKPKQ KVIIADCGEY
     V
//
